Meihua International Medical Technologies Co., Ltd. (MHUAF)
ValueMarkers Composite Index
98% below intrinsic value ($413)
Meihua International Medical Technologies Co., Ltd. (MHUAF) — VMCI valuation read
Composite valuation read on MHUAF: VMCI 64/100 against a Healthcare sector median of 50. The 14-point above-median print is the headline number for Meihua International Medical Technologies Co., Ltd., and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.
Trailing 30-day insider activity for MHUAF: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.
**Investor frame.** Value, quality, risk in three lines on MHUAF: MHUAF trades at 17.0x earnings, 6% below the Healthcare median of 18.0x; ROIC of 9.0% trails the Healthcare median (10.0%) by 1.0pp; net debt to EBITDA of 3.2x is the binding constraint on the bear case. EV/EBITDA at 14.0x versus 12.0x for Healthcare closes the value frame.
MHUAF rose 3.6% over the trailing 7 days, with a -10.0% read on a 30-day basis.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.